학술논문
ESPAC-4: A multicenter, international, open-label randomized controlled phase III trial of adjuvant combination chemotherapy of gemcitabine (GEM) and capecitabine (CAP) versus monotherapy gemcitabine in patients with resected pancreatic ductal adenocarcinoma: Five year follow-up.
Document Type
Journal
Author
Neoptolemos, John P.; Palmer, Daniel H.; Ghaneh, Paula; Valle, Juan W.; Cunningham, David; Wadsley, Jonathan; Meyer, Tim; Anthoney, Alan; Glimelius, Bengt; Falk, Stephen; Segersvard, Ralf; Middleton, Gary William; Ross, Paul J.; Wasan, Harpreet Singh; McDonald, Alec; Crosby, Tom David Lewis; Psarelli, Eftychia Eirini; Hammel, Pascal; Hackert, Thilo; Buchler, Markus W.; European Study Grp Pancreatic Canc
Source
Subject
Language
English
ISSN
15277755